Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: PTGX) | Delayed: 141.12 +0.80 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.32 | 52 Week High | $24.52 | |||
| Open | $140.08 | 52 Week Low | $10.02 | |||
| Day High | $142.37 | P/E | N/A | |||
| Day Low | $137.91 | EPS | $0.00 | |||
| Volume | 865,926 | |||||
